🚀 VC round data is live in beta, check it out!
Concord Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Concord Medical and similar public comparables like Limes Schlosskliniken, Suraksha Diagnostics, Centrum Medyczne ENEL-MED, AirSculpt and more.
Concord Medical Overview
About Concord Medical
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
Founded
2008
HQ
Employees
567
Website
Sectors
Financials (FY)
EV
$575M
Concord Medical Financials
Concord Medical reported last fiscal year revenue of $67M and negative EBITDA of ($5M).
In the same fiscal year, Concord Medical generated $5M in gross profit, ($5M) in EBITDA losses, and had net loss of ($38M).
Concord Medical P&L
In the most recent fiscal year, Concord Medical reported revenue of $67M and EBITDA of ($5M).
Concord Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $67M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $5M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($5M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (7%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (48%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($38M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (56%) | XXX | XXX | XXX |
| Net Debt | — | — | $395M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Concord Medical Stock Performance
Concord Medical has current market cap of $164M, and enterprise value of $575M.
Market Cap Evolution
Concord Medical's stock price is $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $575M | $164M | 2.6% | XXX | XXX | XXX | $-0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialConcord Medical Valuation Multiples
Concord Medical trades at 8.5x EV/Revenue multiple, and (117.4x) EV/EBITDA.
Concord Medical Financial Valuation Multiples
As of April 18, 2026, Concord Medical has market cap of $164M and EV of $575M.
Equity research analysts estimate Concord Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Concord Medical has a P/E ratio of (4.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $164M | XXX | $164M | XXX | XXX | XXX |
| EV (current) | $575M | XXX | $575M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 8.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (117.4x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (17.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 122.7x | XXX | XXX | XXX |
| P/E | — | XXX | (4.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (15.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Concord Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Concord Medical Margins & Growth Rates
Concord Medical's revenue in the last fiscal year grew by 18%.
Concord Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Concord Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (7%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (86%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 29% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 54% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Concord Medical Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Concord Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Limes Schlosskliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Suraksha Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Centrum Medyczne ENEL-MED | XXX | XXX | XXX | XXX | XXX | XXX |
| AirSculpt | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Concord Medical M&A Activity
Concord Medical acquired XXX companies to date.
Last acquisition by Concord Medical was on XXXXXXXX, XXXXX. Concord Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Concord Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialConcord Medical Investment Activity
Concord Medical invested in XXX companies to date.
Concord Medical made its latest investment on XXXXXXXX, XXXXX. Concord Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Concord Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Concord Medical
| When was Concord Medical founded? | Concord Medical was founded in 2008. |
| Where is Concord Medical headquartered? | Concord Medical is headquartered in China. |
| How many employees does Concord Medical have? | As of today, Concord Medical has over 567 employees. |
| Is Concord Medical publicly listed? | Yes, Concord Medical is a public company listed on HKEX. |
| What is the stock symbol of Concord Medical? | Concord Medical trades under 02453 ticker. |
| When did Concord Medical go public? | Concord Medical went public in 2024. |
| Who are competitors of Concord Medical? | Concord Medical main competitors are Limes Schlosskliniken, Suraksha Diagnostics, Centrum Medyczne ENEL-MED, AirSculpt. |
| What is the current market cap of Concord Medical? | Concord Medical's current market cap is $164M. |
| What is the current revenue of Concord Medical? | Concord Medical's last fiscal year revenue is $67M. |
| What is the current EV/Revenue multiple of Concord Medical? | Current revenue multiple of Concord Medical is 8.5x. |
| Is Concord Medical profitable? | No, Concord Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.